AllianceBernstein’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Hold
36,010
﹤0.01% 2249
2025
Q1
$1.07M Hold
36,010
﹤0.01% 2204
2024
Q4
$1.03M Sell
36,010
-66,120
-65% -$1.89M ﹤0.01% 2315
2024
Q3
$3.95M Sell
102,130
-28,620
-22% -$1.11M ﹤0.01% 1625
2024
Q2
$4.21M Hold
130,750
﹤0.01% 1559
2024
Q1
$5.08M Sell
130,750
-29,040
-18% -$1.13M ﹤0.01% 1459
2023
Q4
$4.92M Buy
159,790
+11,663
+8% +$359K ﹤0.01% 1502
2023
Q3
$3.31M Buy
148,127
+54,227
+58% +$1.21M ﹤0.01% 1599
2023
Q2
$2.02M Buy
93,900
+55,600
+145% +$1.19M ﹤0.01% 1889
2023
Q1
$919K Sell
38,300
-4,954
-11% -$119K ﹤0.01% 2275
2022
Q4
$1M Sell
43,254
-52
-0.1% -$1.21K ﹤0.01% 2271
2022
Q3
$694K Buy
43,306
+66
+0.2% +$1.06K ﹤0.01% 2481
2022
Q2
$766K Sell
43,240
-39
-0.1% -$691 ﹤0.01% 2478
2022
Q1
$881K Buy
43,279
+150
+0.3% +$3.05K ﹤0.01% 2461
2021
Q4
$806K Sell
43,129
-35
-0.1% -$654 ﹤0.01% 2538
2021
Q3
$852K Sell
43,164
-1,580
-4% -$31.2K ﹤0.01% 2544
2021
Q2
$1.06M Hold
44,744
﹤0.01% 2498
2021
Q1
$1.06M Buy
44,744
+1,844
+4% +$43.7K ﹤0.01% 2373
2020
Q4
$859K Hold
42,900
﹤0.01% 2352
2020
Q3
$893K Sell
42,900
-61,560
-59% -$1.28M ﹤0.01% 2231
2020
Q2
$1.83M Hold
104,460
﹤0.01% 1881
2020
Q1
$1.71M Sell
104,460
-34,050
-25% -$556K ﹤0.01% 1753
2019
Q4
$2.85M Hold
138,510
﹤0.01% 1755
2019
Q3
$1.59M Buy
138,510
+5,400
+4% +$62K ﹤0.01% 2043
2019
Q2
$1.75M Buy
133,110
+21,070
+19% +$277K ﹤0.01% 2042
2019
Q1
$1.7M Buy
112,040
+13,990
+14% +$212K ﹤0.01% 1980
2018
Q4
$1.68M Buy
98,050
+60,850
+164% +$1.05M ﹤0.01% 1925
2018
Q3
$548K Hold
37,200
﹤0.01% 2566
2018
Q2
$887K Buy
37,200
+1,900
+5% +$45.3K ﹤0.01% 2357
2018
Q1
$902K Buy
35,300
+7,700
+28% +$197K ﹤0.01% 2298
2017
Q4
$509K Hold
27,600
﹤0.01% 2511
2017
Q3
$290K Hold
27,600
﹤0.01% 2768
2017
Q2
$345K Buy
27,600
+12,000
+77% +$150K ﹤0.01% 2738
2017
Q1
$157K Hold
15,600
﹤0.01% 2874
2016
Q4
$243K Buy
15,600
+4,300
+38% +$67K ﹤0.01% 2795
2016
Q3
$218K Buy
11,300
+1,000
+10% +$19.3K ﹤0.01% 2797
2016
Q2
$122K Buy
+10,300
New +$122K ﹤0.01% 2879